Alerts will be sent to your verified email
Verify EmailVEERHEALTH
|
Veerhealth Care
|
Vista Pharma
|
Vivimed Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.69 % | 0.0 | 184.61 % |
|
5yr average Equity Multiplier
|
1.35 | 1.42 | -33.72 |
|
5yr Average Asset Turnover Ratio
|
0.51 | 0.08 | 0.27 |
|
5yr Avg Net Profit Margin
|
3.95 % | -205.63 % | -54.08 % |
|
Price to Book
|
2.09 | 1.32 | 0.0 |
|
P/E
|
88.03 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
43.62 Days | 124.89 Days | 184.52 Days |
|
Inventory Days
|
56.8 Days | 3040.44 Days | 244.76 Days |
|
Days Receivable
|
78.02 Days | 137.33 Days | 246.32 Days |
|
Days Payable
|
63.05 Days | 1845.08 Days | 159.64 Days |
|
5yr Average Interest Coverage Ratio
|
208.02 | -2.88 | -6.61 |
|
5yr Avg ROCE
|
3.74 % | -8.17 % | -13.87 % |
|
5yr Avg Operating Profit Margin
|
0.37 % | -192.46 % | -26.56 % |
|
5 yr average Debt to Equity
|
0.07 | 0.26 | -13.68 |
|
5yr CAGR Net Profit
|
0.52 % | 19.73 % | -14.97 % |
|
5yr Average Return on Assets
|
2.06 % | -6.49 % | -10.44 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
31.5 % | 21.19 % | 7.57 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 15.18 % |
|
Change in Promoter Holding (3 Yrs)
|
0.74 % | -14.25 % | -13.37 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -0.02 % | 0.0 |
|
Veerhealth Care
|
Vista Pharma
|
Vivimed Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|